Spinal Muscular Atrophy Type III Non Ambulant
1 clinical trials · Condition
◉ Watch Spinal Muscular Atrophy Type III Non Ambulant
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. (NCT01302600) | Hoffmann-La Roche | 2010-11-01 |
Track Spinal Muscular Atrophy Type III Non Ambulant automatically
Every clearance here is in the API, with alerts when new ones post.